» Articles » PMID: 12149213

Functional Interleukin-7 Receptors (IL-7Rs) Are Expressed by Marrow Stromal Cells: Binding of IL-7 Increases Levels of IL-6 MRNA and Secreted Protein

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Aug 1
PMID 12149213
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

DNA spotted microarrays were used to compare gene expression profiles from 2 functionally distinct human marrow stromal cell lines: HS-27a, which supports cobblestone area formation by early hematopoietic progenitors, and HS-5, which secretes multiple cytokines that support the proliferation of committed progenitors. One unexpected result was the high level of interleukin-7 receptor (IL-7R) gene expression in HS-27a stromal cells. Northern blot analysis confirmed the IL-7R RNA expression, and Western blots for the IL-7R protein detected both a full-length (90-kd) IL-7R and a smaller 30-kd fragment in both HS-27a cells and primary stromal cell cultures, whereas only the 90-kd receptor protein was detected in peripheral blood mononuclear cells. Biotinylated IL-7 was shown to bind to HS-27a cells under physiologic conditions, and this binding was inhibited by blocking anti-IL-7 antibodies. Tyrosine phosphorylation of several proteins (55 kd, 30 kd, and 24 kd) in HS-27a cells was rapidly increased after incubation with recombinant IL-7. One of the phosphorylated proteins proved to be the 30-kd IL-7R fragment. Exposure of HS-27a cells to IL-7 resulted in a 10-fold increase in secretion of IL-6 into culture supernatants but no increase in the cytokines stromal cell-derived factor 1, macrophage inflammatory protein 1 alpha, or IL-1 beta. The up-regulation of IL-6 secretion is associated with a rapid but transient increase in detectable levels of IL-6 messenger RNA. These data suggest that IL-7 may function to regulate the milieu of the microenvironment by modulating IL-6 secretion by the IL-7R-expressing stromal elements.

Citing Articles

The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.

Wang C, Kong L, Kim S, Lee S, Oh S, Jo S Int J Mol Sci. 2022; 23(18).

PMID: 36142322 PMC: 9499417. DOI: 10.3390/ijms231810412.


Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL.

Rejeski K, Wu Z, Blumenberg V, Kunz W, Muller S, Kajigaya S Blood. 2022; 140(20):2175-2179.

PMID: 35776908 PMC: 9837444. DOI: 10.1182/blood.2022017015.


Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Bednarz-Misa I, Bromke M, Krzystek-Korpacka M Adv Exp Med Biol. 2021; 1290:9-49.

PMID: 33559853 DOI: 10.1007/978-3-030-55617-4_2.


Comment on "Fibroblasts in Nodular SclerosingClassical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury" 2019, 11, 1687.

Aldinucci D, Colombatti A Cancers (Basel). 2020; 12(2).

PMID: 32028697 PMC: 7072697. DOI: 10.3390/cancers12020343.


IL-7 suppresses osteogenic differentiation of periodontal ligament stem cells through inactivation of mitogen-activated protein kinase pathway.

Jian C, Fan Q, Hu Y, He Y, Li M, Zheng W Organogenesis. 2016; 12(4):183-193.

PMID: 27579861 PMC: 5198940. DOI: 10.1080/15476278.2016.1229726.